ClinVar Miner

Submissions for variant NM_001267550.2(TTN):c.43417G>C (p.Asp14473His)

gnomAD frequency: 0.00013  dbSNP: rs397517573
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000040237 SCV000063928 uncertain significance not specified 2015-03-11 criteria provided, single submitter clinical testing The p.Asp11905His variant in TTN has been identified by our laboratory in 1 Ashk enazi Jewish individual with HCM. This variant was also identified in 0.04% (28/ 66604) of European chromosomes by the Exome Aggregation Consortium (ExAC, http:/ /exac.broadinstitute.org; dbSNP rs397517573). Computational prediction tools and conservation analysis suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary , the clinical significance of the p.Asp11905His variant is uncertain.
Eurofins Ntd Llc (ga) RCV000726234 SCV000701309 uncertain significance not provided 2017-01-30 criteria provided, single submitter clinical testing
Ambry Genetics RCV000617879 SCV000735480 likely benign Cardiovascular phenotype 2018-11-23 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
GeneDx RCV000726234 SCV000982650 likely benign not provided 2021-03-09 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001087264 SCV001007171 benign Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J 2025-01-19 criteria provided, single submitter clinical testing
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV001171014 SCV001333683 benign Cardiomyopathy 2018-05-02 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.